Abstract
Introduction Two phase 3 trials in adults with excessive sleepiness (ES) and narcolepsy or ES and obstructive sleep apnea (OSA) demonstrated robust wake-promoting effects of solriamfetol with significant increase in overall mean sleep latency (MSL; mean of first 4/5 …
Cite
CITATION STYLE
APA
Dauvilliers, Y., Arnulf, I., Szakács, Z., Scart-Grès, C., Lecomte, I., Caussé, C., & Schwartz, J. (2018). 0623 Long-Term Evaluation of Safety and Efficacy of Pitolisant In Narcolepsy: Harmony III Study. Sleep, 41(suppl_1), A231–A232. https://doi.org/10.1093/sleep/zsy061.622
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free